Aethlon Medical reports second cohort data in Australian cancer study

July 13, 2026 8:02 AM

Aethlon Medical, Inc. (NASDAQ: AEMD) reported that patients in the second cohort of its Australian oncology feasibility study showed biological ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found